The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.
The aim of this study was to characterize and identify the mode of action of IC31®, a two-component vaccine adjuvant. We found that IC31® was accumulated in human peripheral blood monocytes, MHC class II positive cells and monocyte-derived DCs (moDCs) but not in plasmacytoid DCs (pDCs). In the prese...
Main Authors: | Attila Szabo, Peter Gogolak, Kitti Pazmandi, Katalin Kis-Toth, Karin Riedl, Benjamin Wizel, Karen Lingnau, Attila Bacsi, Bence Rethi, Eva Rajnavolgyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3566214?pdf=render |
Similar Items
-
Correction: The Two-Component Adjuvant IC31® Boosts Type I Interferon Production of Human Monocyte-Derived Dendritic Cells via Ligation of Endosomal TLRs
Published: (2013-01-01) -
MSC-like cells increase ability of monocyte-derived dendritic cells to polarize IL-17-/IL-10-producing T cells via CTLA-4
by: Anett Mázló, et al.
Published: (2021-04-01) -
Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation
by: Tünde Fekete, et al.
Published: (2018-12-01) -
Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells
by: Tünde Fekete, et al.
Published: (2018-10-01) -
Ragweed subpollen particles of respirable size activate human dendritic cells.
by: Kitti Pazmandi, et al.
Published: (2012-01-01)